Oramed Pharmaceuticals
ORMP
ORMP
64 hedge funds and large institutions have $45M invested in Oramed Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.07% less ownership
Funds ownership: 32.81% → 32.74% (-0.07%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
64
Holding in Top 10
2
Calls
$79K
Puts
–
Top Buyers
| 1 | +$6.48M | |
| 2 | +$527K | |
| 3 | +$472K | |
| 4 |
OSAM
O'Shaughnessy Asset Management
Stamford,
Connecticut
|
+$395K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$374K |
Top Sellers
| 1 | -$1.22M | |
| 2 | -$330K | |
| 3 | -$166K | |
| 4 |
RC
RBF Capital
San Francisco,
California
|
-$122K |
| 5 |
QC
Quadrature Capital
London,
United Kingdom
|
-$119K |
